View : 10 Download: 0

Full metadata record

DC Field Value Language
dc.contributor.author김완규-
dc.date.accessioned2026-11-17T16:30:03Z-
dc.date.available2026-11-17T16:30:03Z-
dc.date.issued2026-
dc.identifier.issn1201-9712-
dc.identifier.issn1878-3511-
dc.identifier.otherOAK-40559-
dc.identifier.urihttps://dspace.ewha.ac.kr/handle/2015.oak/276905-
dc.description.abstractObjectives: Few large-scale population-based studies have examined the association between COVID-19 and respiratory aspergillosis. Using nationwide data, we investigated whether SARS-CoV-2 infection increases respiratory aspergillosis incidence and whether COVID-19-associated aspergillosis affects COVID19 severity. We also analyzed public COVID-19 transcriptomic datasets to assess effects on airway structural and immune cells. Design or Methods : From a nationwide cohort of 8.5 million clinical registries, we included over 550,0 0 0 patients diagnosed with COVID-19 between October 8, 2020, and December 31, 2021, and matched controls. Outcomes were respiratory aspergillosis incidence, including invasive and noninvasive forms, and its association with COVID-19 severity. Results: COVID-19 was associated with increased subsequent respiratory aspergillosis. Diabetes, COPD, and other comorbidities further increased fungal infection incidence among COVID-19 patients. Both invasive and noninvasive aspergillosis were associated with greater COVID-19 severity. Systemic corticosteroid use markedly increased severity and mortality in both forms. Antifungal-related genes and pathways, including CCR6, CXCL9, and CX3CR1, were consistently downregulated after SARS-CoV-2 infection and/or corticosteroid treatment. Conclusion: COVID-19 was associated with increased respiratory aspergillosis incidence, and respiratory aspergillosis was associated with worse COVID-19 outcomes regardless of invasiveness. Further studies should evaluate whether antifungal treatment improves COVID-19 outcomes. on behalf of International Society for Infectious ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )-
dc.languageEnglish-
dc.publisherELSEVIER SCI LTD-
dc.subjectCOVID-19-
dc.subjectRespiratory aspergillosis-
dc.subjectTranscriptome-
dc.titleNoninvasive aspergillosis following COVID-19 exacerbates the severity of SARS-CoV-2 infection-
dc.typeArticle-
dc.relation.volume172-
dc.relation.indexSCIE-
dc.relation.indexSCOPUS-
dc.relation.journaltitleINTERNATIONAL JOURNAL OF INFECTIOUS DISEASES-
dc.identifier.doi10.1016/j.ijid.2026.109095-
dc.identifier.wosidWOS:001888332200001-
dc.identifier.scopusid2-s2.0-105051572753-
dc.author.googleKim, Jong Seung-
dc.author.googlePark, Jun Hyung-
dc.author.googleKim, Juhyun-
dc.author.googleLee, Yong Chul-
dc.author.googleYang, Ji Won-
dc.author.googleYou, Yeon Seok-
dc.author.googleKim, Gwangsu-
dc.author.googleKim, Wankyu-
dc.author.googleJeong, Jae Seok-
dc.contributor.scopusid김완규(25627654100)-
dc.date.modifydate20261117125951-
Appears in Collections:
자연과학대학 > 생명과학전공 > Journal papers
Files in This Item:
There are no files associated with this item.
Export
RIS (EndNote)
XLS (Excel)
XML


qrcode

BROWSE